Literature DB >> 11691815

The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.

M Kuraguchi1, K Yang, E Wong, E Avdievich, K Fan, R D Kolodner, M Lipkin, A M Brown, R Kucherlapati, W Edelmann.   

Abstract

In mammalian cells, mismatch recognition has been attributed to two partially redundant heterodimeric protein complexes of MutS homologues, MSH2-MSH3 and MSH2-MSH6. We have conducted a comparative analysis of Msh3 and Msh6 deficiency in mouse intestinal tumorigenesis by generating Apc1638N mice deficient in Msh3, Msh6 or both. We have found that Apc1638N mice defective in Msh6 show reduced survival and a 6-7-fold increase in intestinal tumor multiplicity. In contrast, Msh3-deficient Apc1638N mice showed no difference in survival and intestinal tumor multiplicity as compared with Apc1638N mice. However, when Msh3 deficiency is combined with Msh6 deficiency (Msh3(-/-)Msh6(-/-)Apc1638N), the survival rate of the mice was further reduced compared to Msh6(-/-)Apc(1638N) mice because of a high multiplicity of intestinal tumors at a younger age. Almost 90% of the intestinal tumors from both Msh6(-/-)Apc1638N and Msh3(-/-)Msh6(-/-)Apc1638N mice contained truncation mutations in the wild-type Apc allele. Apc mutations in Msh6(-/-)Apc1638N mice consisted predominantly of base substitutions (93%) creating stop codons, consistent with a major role for Msh6 in the repair of base-base mismatches. However, in Msh3(-/-)Msh6(-/-)Apc1638N tumors, we observed a mixture of base substitutions (46%) and frameshifts (54%), indicating that in Msh6(-/-)Apc1638N mice frameshift mutations in the Apc gene were suppressed by Msh3. Interestingly, all except one of the Apc mutations detected in mismatch repair-deficient intestinal tumors were located upstream of the third 20-amino acid beta-catenin binding repeat and before all of the Ser-Ala-Met-Pro repeats, suggesting that there is selection for loss of multiple domains involved in beta-catenin regulation. Our analysis therefore has revealed distinct mutational spectra and clarified the roles of Msh3 and Msh6 in DNA repair and intestinal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691815

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Clonal structure of carcinogen-induced intestinal tumors in mice.

Authors:  Andrew T Thliveris; Linda Clipson; Alanna White; Jesse Waggoner; Lauren Plesh; Bridget L Skinner; Christopher D Zahm; Ruth Sullivan; William F Dove; Michael A Newton; Richard B Halberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

Review 2.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

3.  Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.

Authors:  Denise Campisi Hegan; Latha Narayanan; Frank R Jirik; Winfried Edelmann; R Michael Liskay; Peter M Glazer
Journal:  Carcinogenesis       Date:  2006-05-25       Impact factor: 4.944

4.  Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.

Authors:  Kan Yang; Natalia V Popova; Wan Cai Yang; Ioanna Lozonschi; Selam Tadesse; Scott Kent; Laura Bancroft; Ilze Matise; Robert T Cormier; Stefan J Scherer; Winfried Edelmann; Martin Lipkin; Leonard Augenlicht; Anna Velcich
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

5.  Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.

Authors:  Edmund Wong; Kan Yang; Mari Kuraguchi; Uwe Werling; Elena Avdievich; Kunhua Fan; Melissa Fazzari; Bo Jin; Anthony M C Brown; Martin Lipkin; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

6.  The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

Authors:  J M M van Oers; Y Edwards; R Chahwan; W Zhang; C Smith; X Pechuan; S Schaetzlein; B Jin; Y Wang; A Bergman; M D Scharff; W Edelmann
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

Review 7.  Interaction between APC and Fen1 during breast carcinogenesis.

Authors:  Satya Narayan; Aruna S Jaiswal; Brian K Law; Mohammad A Kamal; Arun K Sharma; Robert A Hromas
Journal:  DNA Repair (Amst)       Date:  2016-04-07

Review 8.  Murine models of colorectal cancer.

Authors:  Joshua M Uronis; David W Threadgill
Journal:  Mamm Genome       Date:  2009-05-15       Impact factor: 2.957

Review 9.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

10.  Genetic mechanisms in Apc-mediated mammary tumorigenesis.

Authors:  Mari Kuraguchi; Nana Yaw Ohene-Baah; Dmitriy Sonkin; Roderick Terry Bronson; Raju Kucherlapati
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.